Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment

Published:2020-08-06 Issue:8 Volume:3 Page:e2012252
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Hajjar Ihab¹²,Okafor Maureen¹,McDaniel Darius¹,Obideen Malik¹,Dee Elizabeth¹,Shokouhi Mahsa¹,Quyyumi Arshed A.³,Levey Allan¹,Goldstein Felicia¹

Affiliation:

1. Department of Neurology, Emory University School of Medicine, Atlanta, Georgia

2. Division of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

3. Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2769104/hajjar_2020_oi_200465.pdf

Reference57 articles.

1. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.;Williamson;JAMA,2019

2. A15294 Effects of antihypertensive therapy on cognitive function and health-related quality of life in high-risk hypertensive patients.;Ma;J Hypertens,2018

3. Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function.;Gorelick;J Am Soc Hypertens,2012

4. Hypertension and cognitive decline: impact on executive function.;Vicario;J Clin Hypertens (Greenwich),2005

5. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer’s disease.;Marshall;Alzheimers Dement,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive medications and dementia in older adults with hypertension;2024-08-29

2. Multi-target drugs for Alzheimer's disease;Trends in Pharmacological Sciences;2024-07

3. Current therapeutics for Alzheimer’s disease and clinical trials;Exploration of Neuroscience;2024-06-27

4. Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer Disease;2024-06-21

5. Alzheimer's Disease Clinical Trials: What Have We Learned From Magnetic Resonance Imaging;Journal of Magnetic Resonance Imaging;2024-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3